These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2008 related items for PubMed ID: 26514948

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [Abstract] [Full Text] [Related]

  • 23. Circulating omentin-1 levels and inflammation in polycystic ovary syndrome.
    Franik G, Sadlocha M, Madej P, Owczarek A, Skrzypulec-Plinta V, Plinta R, Chudek J, Olszanecka-Glinianowicz M.
    Ginekol Pol; 2020; 91(6):308-312. PubMed ID: 32627151
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
    Hu WH, Qiao J, Li MZ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 20; 87(11):721-4. PubMed ID: 17565837
    [Abstract] [Full Text] [Related]

  • 28. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
    Daghestani MH, Daghestani MH, Warsy A, El-Ansary A, Omair MA, Omair MA, Hassen LM, Alhumaidhi EM, Al Qahtani B, Harrath AH.
    Front Endocrinol (Lausanne); 2021 Mar 20; 12():665446. PubMed ID: 34122339
    [Abstract] [Full Text] [Related]

  • 29. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
    Guzel EC, Celik C, Abali R, Kucukyalcin V, Celik E, Guzel M, Yilmaz M.
    Gynecol Endocrinol; 2014 Jun 20; 30(6):419-22. PubMed ID: 24524360
    [Abstract] [Full Text] [Related]

  • 30. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.
    Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun 20; 156(2):181-5. PubMed ID: 21353371
    [Abstract] [Full Text] [Related]

  • 31. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 20; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
    Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS.
    Diabetes; 2008 Apr 20; 57(4):801-8. PubMed ID: 18174521
    [Abstract] [Full Text] [Related]

  • 34. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 20; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 35. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun 20; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 36. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T, Tsutsumi O, Taketani Y.
    Gynecol Endocrinol; 2008 Jul 20; 24(7):385-91. PubMed ID: 18645711
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M.
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct 20; 158(2):254-9. PubMed ID: 21752527
    [Abstract] [Full Text] [Related]

  • 39. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Madej P, Wdowczyk M, Owczarek A, Chudek J.
    Eur J Endocrinol; 2015 Feb 20; 172(2):173-9. PubMed ID: 25411238
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 101.